How poxviruses oppose apoptosis

Seminars in Virology

Volumn 8, Issue 5, 1998, Pages 429-442

  McFadden, Grant ^a   Barry, Michele ^b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bcl 2 homologs; Caspase inhibitors; crmA; Host range; PKR; Serpin; TNF

Indexed keywords

ENZYME INHIBITOR; PROTEIN BCL 2; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; DNA VIRUS; HUMAN; HUMAN CELL; NONHUMAN; POXVIRUS; PROTEIN EXPRESSION; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; POXVIRIDAE;

EID: 0031833929     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1997.0141     Document Type: Article

References (154)

1. Hale A. J., Smith C. A., Sutherland L. C., Stoneman V. E. A., Longthorne V. L., Chulhane A. C., Williams G. T. Apoptosis: Molecular regulation of cell death. Eur. J. Biochem. 236:1996;1-26.
2. Wertz I. E., Hanley M. R. Diverse molecular provocation of programmed cell death. Trends Biochem. Sci. 21:1996;359-364.
3. White E. Life, death and the pursuit of apoptosis. Genes Dev. 10:1996;1-15.
4. Rudin C. M., Thompson C. B. Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu. Rev. Med. 48:1997;267-281.
5. Collins M. Potential roles of apoptosis in viral pathogenesis. Am. J. Respir. Crit. Care Med. 152:1995;S20-S24.
6. Razvi E. S., Welsh R. M. Apoptosis in viral infections. Adv. Virus Res. 45:1995;1-60.
7. Shen Y., Shenk T. E. Viruses and apoptosis. Curr. Opin. Genet. Dev. 5:1995;105-111.
8. Cuff S., Ruby J. Evasion of apoptosis by DNA viruses. Immunol. Cell. Biol. 74:1996;527-537.
9. Teodoro J. G., Branton P. E. Regulation of apoptosis by viral gene products. J. Virol. 71:1997;1739-1746.
10. Moss B. Replication of poxviruses. Virology. 1990;Raven Press, New York. p. 2079-2111.
11. McFadden G., Graham K., Ellion K., Barry M., Macen J., Schreiber M., Mossman K., Nash P., Lalani A., Everett H. Interruption of cytokine networks by poxviruses: Lessons from myxoma virus. J. Leukocyte Biol. 57:1995;731-738.
12. Gemmell A., Fenner F. Genetic studies with mammalian poxviruses. III. White (u) mutants of rabbitpox virus. Virology. 11:1960;219-235.
13. Fenner F., Sambrook J. F. Conditional lethal mutants of rabbitpox virus. II. Mutants (p) that fail to multiply in PK-2a cells. Virology. 28:1966;600-609.
14. Drillien R., Spehner D., Kirn A. Host range restriction of vaccinia virus in Chinese hamster ovary cells: Relationship to shutoff of protein synthesis. J. Virol. 28:1978;843-850.
15. Hruby D. E., Lynn D. L., Condit R. C., Kates J. R. Cellular differences in the molecular mechanisms of vaccinia virus host range restriction. J. Gen. Virol. 47:1980;485-488.
16. Ramsey-Ewing A., Moss B. Recombinant protein synthesis in Chinese hamster ovary cells using a vaccinia virus/bacteriophage T7 hybrid expression system. J. Biol. Chem. 271:1996;16962-16966.
17. Spehner D., Gillard S., Drillien R., Kirn A. A cowpox virus gene required for multiplication in Chinese hamster ovary cells. J. Virol. 62:1988;1297-1304.
18. Ramsey-Ewing A., Moss B. Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis. Virology. 206:1995;984-993.
19. Ink B. S., Gilbert C. S., Evans G. I. Delay of vaccinia virus-induced apoptosis in nonpermissive Chinese hamster ovary cells by the cowpox virusCHOhrand adenovirusE1B 19Kgenes. J. Virol. 69:1995;661-668.
20. Mossman K., Lee S. F., Barry M., Boshkov L., McFadden G. Disruption of M-T5, a novel myxoma virus gene member of the poxvirus host range superfamily, results in dramatic attentuation of myxomatosis in infected European rabbits. J. Virol. 70:1996;4394-4410.
21. McFadden G., Graham K., Opgenorth A. Poxvirus growth factors. McFadden G. Viroceptors, Virokines and Related Immune Modulators Encoded by DNA Viruses. 1995;1-15 R. G. Landes, Austin.
22. Pickup D. J., Ink B. S., Hu W., Ray C. A., Joklik W. K. Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine protease. Proc. Natl. Acad. Sci. USA. 83:1986;7698-7702.
23. Ray C. A., Black R. A., Kronheim S. R., Greenstreet T. A., Sleath P. R., Salvesen G. S., Pickup D. J. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell. 69:1992;597-604.
24. Bowden R. J., Simas J. P., Davis A. J., Efstathiou S. Murine gammaherpesvirus 68 encodes TRNA-like sequences which are expressed during latency. J. Gen. Virol. 78:1997;1675-1687.
25. Virgin H. W., Latreille P., Wamsley P., Hallsworth K., Weck K. E., Dal Canto A. J., Speck S. H. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:1997;5894-5904.
26. Turner, P. C. Musy, P. W. Moyer, R. W. 1995, Poxvirus serpins, In, Viroceptors, Virokines and Related Immune Modulators Encoded By DNA Viruses, G. McFadden, 67, 88, R. G. Landes, Austin, TX.
27. Black R. A., Kronheim S. R., Cantrell M., Deeley M. C., March C. J., Prichett K. S., Wignall J., Conlon P. J., Cosman D., Hopp T. P. Generation of biologically active interleukin-1β by proteolytic cleavage of the inactive percursor. J. Biol. Chem. 263:1989;9437-9442.
28. Kostura M. J., Tocci M. J., Limjuco G., Chin J., Cameron P., Hillman A. G., Chartain N. A., Schmidt J. A. Identification of a monocyte specific pre-interleukin1β convertase activity. Proc. Natl. Acad. Sci. USA. 86:1989;5227-5231.
29. Cerretti D. P., Kozlosky C. J., Moseley B., Nelson N., Van Ness K., Greenstreet T. A., March C. J., Kronheim S. R., Druck T., Cannizzaro L. A., Huebner K., Black R. A. Molecular cloning of the IL-1β converting enzyme. Science. 256:1992;97-100.
30. Kumar S. ICE-like proteases in apoptosis. Trends Biochem. Sci. 20:1995;198-202.
31. Henkart P. A. ICE family proteases: mediators of all apoptotic cell death. Immunity. 4:1996;195-201.
32. Komiyama T., Ray C. A., Pickup D. J., Howard A. D., Thornberry N. A., Peterson E. P., Salvesen G. Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA: An example of cross-class inhibition. J. Biol. Chem. 269:1994;19331-19337.
33. Miura M., Zhu H., Rotello R., Hatweig E. A., Yuan J. Induction of apoptosis in fibroplasts by IL-1β-converting enzyme, a mammalian homolog of theC. eleganscell death gene ced-3. Cell. 75:1993;653-660.
34. Enari M., Hug H., Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 375:1995;78-81.
35. Los M., Van d. C. M., Penning L. C., Schenk H., Westendorp M., Baeuerle P. A., Droge W., Krammer P. H., Fiers W., Schulze-Osthoff K. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature. 375:1995;81-83.
36. Tewari M., Dixit V. M. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270:1995;3255-3260.
37. Miura M., Friedlander R. M., Yuan J. Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc. Natl. Acad. Sci. USA. 92:1995;8318-8322.
38. Henkart P. A. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity. 1:1994;343-346.
39. Atkinson E. A., Bleackley R. C. Mechanisms of lysis by cytotoxic T cells. Crit. Rev. Immunol. 15:1995;359-384.
40. Tewari M., Telford W. G., Miller R. A., Dixit V. M. Crm A, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J. Biol. Chem. 270:1995;22705-22708.
41. Quan L. T., Caputo A., Bleackley R. C., Pickup D. J., Salvesen G. S. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J. Biol. Chem. 270:1995;10377-10379.
42. Wang L., Miura M., Bergeron L., Zhu H., Yuan J. Y. Ich-1 and ICE-ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell. 78:1994;739-750.
43. Gagliardini V., Fernandez P. A., Lee R. K., Drexler H. C., Rotello R. J., Fishman M. C., Yuan J. Prevention of vertebrate neuronal death by the crmA gene. Science. 263:1994;826-828.
44. Boudreau N., Sympson C. J., Werb Z., Bissell M. J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 267:1995;891-893.
45. Kuida K., Lippke J. A., Ku G., Harding M. W., Livingston D. J., Su M. S. S., Flavell R. A. Altered cytokine export and apoptosis in mice deficient in Interleukin-1β converting enzyme. Science. 267:1995;2000-2003.
46. Li P., Allen H., Banerjee S., Franklin S., Herzog L., Johnston C., McDowell J., Paskind M., Rodman L., Salfeld J., Towne E., Tracey D., Wardwell S., Wei F. Y., Wong W., Kamen R., Seshadri T. Mice deficient in IL-1β converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell. 80:1995;401-411.
47. Zhou Q., Snipas S., Orth K., Muzio M., Dixit V. M., Salvesen G. S. Target protease specificity of the viral serpin CrmA: Analysis of five caspases. J. Biol. Chem. 272:1997;7797-7800.
48. Muzio M., Salvesen G. S., Dixit V. M. FLICE induced apoptosis in a cell-free system: Cleavage of caspase zymogens. J. Biol. Chem. 400:1997;15-18.
49. Kotwal G. J., Moss B. Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily. J. Virol. 63:1989;600-606.
50. Smith G. L., Howard S. T., Chan Y. S. Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors. J. Gen. Virol. 70:1989;2333-2343.
51. Ali A. N., Turner P. C., Brooks M. A., Moyer R. W. The SPI-1 gene of rabbitpox virus determines host range and is required for hemorrhagic pock formation. Virology. 202:1994;305-314.
52. Massung R. F., Esposito J. J., Liu L. I., Qi J., Utterback T. R., Knight J. C., Aubin L., Yuran T. E., Parsons J. M., Loparev V. N., Selivanov N. A., Cavallaro K. F., Kerlavage A. R., Mahy B. W. J., Venter J. C. Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature. 366:1993;748-751.
53. Shchelkunov S. N., Blinov V. M., Sandakchiev L. S. Genes of variola virus and vaccinia viruses necessary to overcome the host protective mechanism. FEBS Lett. 319:1993;80-83.
54. Petit F., Bertagnoli S., Gelfi J., Fassy F., Boucraut-Baralon C., Milon A. Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1β converting enzyme. J. Virol. 70:1996;5860-6866.
55. Kettle S., Blake N. W., Law K. M., Smith G. L. Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology. 206:1995;136-147.
56. Dobbelstein M., Shenk T. Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product. J. Virol. 70:1996;6479-6485.
57. Kettle S., Alcami A., Khanna A., Ehret R., Jassoy C., Smith G. L. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1β converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1β-induced fever. J. Gen. Virol. 78:1997;677-685.
58. Heinkelein M., Pilz S., Jassoy C. Inhibition of CD95 (Fas/Apo1)-mediated apoptosis by vaccinia virus WR. Clin. Exp. Immunol. 103:1996;8-14.
59. Macen J. L., Garner R. S., Musy P. Y., Brooks M. A., Turner P. C., Moyer R. W., McFadden G., Bleackley R. C. Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein. Proc. Natl. Acad. Sci. USA. 93:1996;9108-9113.
60. Takahashi A., Musy P. Y., Martins L. M., Poirier G. G., Moyer R. W., Earnshaw W. C. CrmA/SPI-2 inhibition of an endogenous ICE-related protease responsible for lamin A cleavage and apoptotic nuclear fragmentation. J. Biol. Chem. 271:1996;32487-23490.
61. Ray C. A., Pickup D. J. The mode of death of pig kidney cells infected with cowpox virus is governed by the expression of the crmA gene. Virology. 217:1996;384-391.
62. Blake M. W., Kettle S., Law K. M., Gould K., Bastin J., Townsend A. R., Smith G. L. Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes. J. Gen. Virol. 76:1995;2393-2398.
63. Brooks M. A., Ali A. N., Turner P. C., Moyer R. W. A rabbitpox virus serpin gene controls host range by inhibiting apoptosis in restrictive cells. J. Virol. 69:1995;7688-7698.
64. Itoh N., Nagata S. A novel protein domain required for apoptosis. J. Biol. Chem. 268:1993;10932-10937.
65. Tartaglia L. A., Ayres T. M., Wong G. H. W., Goeddel D. V. A novel domain within the 55kd TNF receptor signals cell death. Cell. 74:1993;845-853.
66. Boldin M. P., Mett I. L., Varfolomeev E. E., Chumakov I., Shemer-Avni Y., Camonis J. H., Wallach D. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J. Biol. Chem. 270:1995;387-391.
67. Chinnaiyan A. M., O'Rourke K., Yu G. L., Tewari M., Dixit V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:1995;505-512.
68. Hsu H., Xiong J., Goeddel D. V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 81:1995;495-504.
69. Hsu H., Shu H. B., Pan M. G., Goeddel D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor-1 signal transduction pathways. Cell. 84:1996;299-308.
70. Boldin M. P., Goncharov T. M., Goltsev Y. V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO1- and TNF receptor-induced cell death. Cell. 1996.
71. Fernandes-Alnemri T., Armstrong R. C., Krebs J., Srinivasula S. M., Wang L., Bullrich F., Fritz L. C., Trapani J. A., Tomaselli K. J., Litwack G., Alnemri E. S. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA. 93:1996;7464-7469.
72. Muzio M., Chinnaiyan A. M., Kischkel F. C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J. D., Zhang M., Gentz R., Mann M., Krammer P. H., Peter M. E., Dixit V. M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO1) death-inducing signaling complex. Cell. 85:1996;817-827.
73. Pickup D. J. Poxviral modifiers of cytokine responses to infection. Infect. Agents Dis. 3:1994;116-126.
74. Spriggs M. K. One step ahead of the game: Viral immunomodulatory molecules. Annu. Rev. Immunol. 14:1996;101-131.
75. Senkevich T. G., Bugert J. J., Sisler J. R., Koonin E. V., Darai G., Moss B. Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science. 273:1996;813-816.
76. Senkevich T. G., Koonin E. V., Bugert J. J., Darai G., Moss B. The genome of molluscum contagiosum virus: Analysis and comparison with other poxviruses. Virology. 233:1997;19-42.
77. Bertin J., Armstrong R. C., Ottilie S., Martin D. A., Wang Y., Banks S., Wang G.-H., Senkevich T. G., Alnemri E. M., Moss B., Lenardo M. J., Tomaselli K. J., Cohen J. I. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;1772-1776.
78. Hu S., Vincenz C., Buller M., Dixit V. M. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272:1997;9621-9624.
79. Thome M., Schneider P., Hofmann K., Fickenscher H., Meinl E., Neipel F., Mattman C., Burns K., Bodmer J. L., Schroter M., Scaffidi C., Krammer P. H., Peter M. E., Tschopp J. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature. 386:1997;517-521.
80. Irmler M., Hahne M., Schneider P., Hofman K., Steiner V., Bodmer J. L., Schroter M., Burns K., Mattmann C., Rimoldi D., French L. E., Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature. 388:1997;190-195.
81. Shu H. B., Halpin D. R., Goeddel D. V. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity. 6:1997;751-763.
82. Jacobson M. D. Apoptosis: Bcl-2-related proteins get connected. Curr. Biol. 71:1997;R277-R281.
83. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:1997;614-620.
84. Henderson S., Huen D., Rowe M., Dawson C., Johnson G., Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA. 90:1993;8479-8483.
85. Smith C. A. A novel viral homologue of Bcl-2 and Ced-9. Trends Cell. Biol. 5:1995;344.
86. Russo J. J., Bohenzky R. A., Chien M. C., Chen J., Yan M., Maddalena D., Parry J. P., Peruzzi D., Edelman I. S., Chang Y. A., Moore P. S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA. 93:1996;14862-14867.
87. Cheng E. H.-Y., Nicholas J., Bellows D. S., Hayward G. S., Guo H.-G., Reitz M. S., Hardwick J. M. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA. 94:1997;690-694.
88. White E., Sabbatini P., Debbas M., Wold W. S. M., Kusher D. I., Gooding L. R. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α Mol. Cell. Biol. 12:1992;2570-2580.
89. Farrow S. N., White J. H., Martinou I., Raven T., Pun K. T., Grinham C. J., Martinou J. C., Brown R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature. 374:1995;731-733.
90. Han J., Sabatini P., Perez D., Rao L., Modha D., White E. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev. 10:1996;461-477.
91. Neilan J. G., Lu Z., Alfonso C. L., Kutish G. F., Sussman M. D., Rock D. L. An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRF1. J. Virol. 67:1993;4391-4394.
92. Yañez R. J., Rodríguez J. M., Nogal M. L., Yuste L., Enríquez C., Rodriguez J. F., Viñuela E. Analysis of the complete nucleotide sequence of African swine fever virus. Virology. 208:1995;249-278.
93. Alfonso C. L., Neilan J. G., Kutish G. F., Rock D. L. An African Swine Fever virus bcl-2 homolog, 5-HL, suppresses apoptotic cell death. J. Virol. 70:1996;4858-4863.
94. Revilla Y., Cebrian A., Baixeras E., Martinez C., Vinuela E., Salas M. L. Inhibition of apoptosis by the African swine fever virus bcl-2 homologue - role of the BH1 domain. Virology. 228:1997;400-404.
95. Brun A., Rivas C., Esteban M., Escribano J. M., Alonso C. African swine fever virus gene A179L, a viral homologue of bcl-2, protects cells from programmed cell death. Virology. 225:1996;227-230.
96. Graham K. A., Opgenorth A., Upton C., McFadden G. Myxoma virus M11L ORF encodes a protein for which cell surface localization is critical in manifestation of viral virulence. Virology. 191:1992;112-124.
97. Opgenorth A., Graham K., Nation N., Strayer D., McFadden G. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J. Virol. 66:1992;4720-4731.
98. Macen J. L., Graham K. A., Lee S. F., Schreiber M., Boshkov L. K., McFadden G. Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes. Virology. 218:1996;232-237.
99. McFadden G., Graham K. Modulation of cytokine networks by poxviruses: The myxoma virus model. Semin. Virol. 5:1994;421-429.
100. Smith C. A., Goodwin R. G. Tumor necrosis factor receptors in the poxvirus family: biological and genetic implications. McFadden G. Viroceptors, Virokines and Related Immune Modulators Encoded by DNA Viruses. 1995;29-40 R. G. Landes, Austin.
101. Sedger L., McFadden G. M-T2: A poxvirus TNF receptor homologue with dual activities. Immunol. Cell. Biol. 74:1996;538-545.
102. McFadden G., Schreiber M., Sedger L. Myxoma T2 protein as a model for poxvirus encoded TNF receptor homologs. J. Neuroimmunol. 72:1997;119-126.
103. Smith C. A., Davis T., Wignall J. M., Din W. S., Farrah T., Upton C., McFadden G., Goodwin R. G. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem. Biophys. Res. Commun. 176:1991;335-342.
104. Schreiber M., McFadden G. The myxoma virus TNF-receptor homologue inhibits TNF in a species specific fashion. Virology. 204:1994;692-705.
105. Schreiber M., Rajarathnam K., McFadden G. Mxyoma virus T2 protein, a tumor necrosis factor (TNF) receptor homolog, is secreted as a monomer and dimer that each bind rabbit TNFα, but the dimer is a more potent TNF inhibitor. J. Biol. Chem. 271:1996;13333-13341.
106. Hu F.-Q., Smith C. A., Pickup D. J. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the Type II TNF receptor. Virology. 204:1994;343-356.
107. Smith C. A., Hu F-Q., Smith T. D., Richards C. L., Smolak P., Goodwin R. G., Pickup D. J. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LTα Virology. 223:1996;132-147.
108. Schreiber M., McFadden G. Mutational analysis of the ligand binding domain of M-T2 protein, the tumor necrosis factor receptor homologue of myxoma virus. J. Immunol. 157:1996;4486-4495.
109. Schreiber M., Sedger L., McFadden G. Distinct domains of M-T2, the myxoma virus TNF receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition. J. Virol. 71:1997;2171-2181.
110. Tewari M., Dixit V. M. Recent advances in tumor necrosis factor and CD40 signaling. Curr. Opin. Genet. Dev. 6:1996;39-44.
111. Ware C. F., VanArsdale S., VanArdsdale T. L. Apoptosis mediated by the TNF-related cytokine and receptor families. J. Cell. Biochem. 60:1996;47-55.
112. Chacon M. R., Almazan F., Nogal M. L., Viñuela E., Rodríguez J. F. The African swine fever virus IAP homolog is a late structural polypeptide. Virology. 214:1995;670-674.
113. Neilan J. G., Lu Z., Kutish G. F., Zsak L., Burrage T. G., Borca M. V., Carrillo C., Rock D. L. A BIR motif containing gene of African swine fever virus, 4CL, is nonessential for growthin vitroand viral virulence. Virology. 230:1997;252-264.
114. Digby M. R., Kimpton W. G., York J. J., Connick T. E., Lowenthal J. W. ITA, a vertebrate homologue of IAP that is expressed in T lymphocytes. DNA Cell Biol. 15:1996;981-988.
115. Deveraux Q. L., Takahashi R., Salvesen G. S., Reed J. C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388:1997;300-304.
116. Rothe M., Pan M. G., Henzel W. J., Ayres T. M., Goeddel D. V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 83:1995;1243-1252.
117. Manji G. A., Hozak R. R., LaCount D. J., Friesen P. D. Baculovirus inhibitor of apoptosis functions at or upstream of the apoptotic suppressor P35 to prevent programmed cell death. J. Virol. 71:1997;4509-4516.
118. Hovanessian A. G. Interferon-induced dsRNA-activated protein kinase (PKR): Antiproliferative, antiviral and antitumoral functions. Semin. Virol. 4:1993;237-245.
119. Jaramillo M. L., Abraham N., Bell J. C. The interferon system: A review with emphasis on the role of PKR in growth control. Cancer Inv. 13:1995;327-338.
120. Samuel C. E., Kuhen K. L., George C. X., Ortega L. G., Rende-Fournier R., Tanaka H. The PKR protein kinase: An interferon-inducible regulator of cell growth and differentiation. International J. Hematol. 65:1997;227-237.
121. Williams B. R. G. Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem. Soc. Trans. 25:1997;509-513.
122. Jacobs B. L., Langland J. O. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology. 219:1996;339-349.
123. Lee S. B., Esteban M. The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of vaccinia virus. Virology. 1993.
124. Lee S. B., Rodríguez D., Rodríguez J. R., Esteban M. The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. Virology. 231:1997;81-88.
125. Perkus M. E., Goebel S. J., Davis S. W., Johnson G. P., Limbach K., Norton E. K., Paoletti E. Vaccinia virus host range proteins. Virology. 179:1990;276-286.
126. McNair A. N. B., Kerr I. M. Viral inhibition of the interferon systems. Pharm. Ther. 56:1993;79-95.
127. Smith G. L., Symons J. A., Alcami A. Poxviruses: Interfering with interferon. Semin. Virol. 1997.
128. Watson J. C., Chang H.-W., Jacobs B. L. Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase. Virology. 185:1991;206-216.
129. Chang H.-W., Watson J. C., Jacobs B. L. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA. 89:1992;4825.
130. Davies M. V., Chang H.-W., Jacobs B. L., Kafman R. J. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J. Virol. 67:1993;1688-1692.
131. Kibler K. V., Shors T., Perkins K. B., Zeman C. C., Banaszak M. P., Biesterfeldt J., Langland J. O., Jacobs B. L. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J. Virol. 71:1997;1992-2003.
132. Beattie E., Denzler K. L., Tartaglia J., Perkus M. E., Paoletti E., Jacobs B. L. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69:1995;499-505.
133. Shors T., Jacobs B. L. Complementation of deletion of the vaccinia virus E3L gene by the Escherichia coli RNase III gene. Virology. 227:1997;77-87.
134. Chang H. W., Jacobs B. L. Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA. Virology. 194:1993;537-547.
135. Chang H. W., Uribe L. H., Jacobs B. L. Rescue of vaccinnia virus lacking the E3L gene by mutants of E3L. J. Virol. 69:1995;6605-6608.
136. Lee S. B., Bablanian R., Esteban M. Regulated expression of the interferon-induced protein kinase p68 (PKR) by vaccinia virus recombinants inhibits the replication of vesicular stomatitis virus but not that of poliovirus. J. Int. Cytol. Res. 16:1996;1073-1078.
137. Mohr I., Gluzman Y. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. EMBO J. 15:1996;4759-4666.
138. Takizawa T., Ohashi K., Nakanishi Y. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J. Virol. 70:1996;8128-8132.
139. Fenner F., Wittek R., Dumbell K. R. The Orthopoxviruses. 1989;Academic Press, London.
140. Ehl S., Hoffmann-Rohrer U., Nagata S., Hengartner H., Zinkernagel R. Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo. J. Immunol. 156:1996;2357-2360.
141. Sambhi S. K., Kohonen-Coris M. R. J., Ramshaw I. A. Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replicationin vivo. Proc. Natl. Acad. Sci. USA. 88:1991;4025-4029.
142. +T cells is dependent on interferon-γ Lymphokine Cytokine Res. 10:1991;353-358.
143. Giavedoni L. D., Jones L., Gardner M. B., Gibson H. L., Ng C. T. L., Barr P. J., Yilma T. Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and γ interferon are attentuated for nude mice. Proc. Natl. Acad. Sci. USA. 89:1992;3409-3413.
144. Ruby J., Bluethmann H., Aguet M., Ramshaw I. A. CD40 ligand has potent antiviral activity. Nature Med. 1:1995;437-441.
145. Melková Z., Lee S. B., Rodriguez D., Esteban M. Bcl-2 prevents nitric oxide-mediated apoptosis and poly (ADP-ribose) polymerase cleavage. FEBS Lett. 403:1997;273-278.
146. Ronen D., Schwartz D., Teitz Y., Goldfinger N., Rotter V. Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Differ. 7:1996;21-30.
147. Diaz-Guerra M., Rivas C., Esteban M. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology. 227:1997;220-228.
148. Chen W., Drillien R., Spehner D., Buller R. M. L. Restricted replication of ectromelia virus in cell culture correlates with mutation in virus-encoded host range genes. Virology. 187:1992;433-442.
149. Beattie E., Kauffman E. B., Martinez H., Perkus M. E., Jacobs B. L., Paoletti E., Tartaglia J. Host-range restriction of vaccinia virus E3L-specific deletion mutants. Virus Genes. 12:1996;89-94.
150. Drillien R., Koehren F., Kirn A. Host range deletion mutant of vaccinia virus defective in human cells. Virology. 111:1981;488-499.
151. Gillard S., Spehner D., Drillien R., Kirn A. Localization and sequence of a vaccinia virus gene required for multiplication in human cells. Proc. Natl. Acad. Sci. USA. 83:1986;5573-5577.
152. Oguiura N., Spehner D., Drillien R. Detection of a protein encoded by the vaccinia virus C7L open reading frame and study of its effect on virus multiplication in different cell lines. J. Gen. Virol. 74:1993;1409-1413.
153. Sutter G., Ramseyewing A., Rosales R., Moss B. Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant. J. Virol. 68:1994;4109-4116.
154. Ramsey-Ewing A. L., Moss B. Complementation of a vaccinia virus host-range K1L gene deletion by the non homologous CP77 gene. Virology. 222:1996;75-86.